Search through
Allopurinol

Allopurinol

CAS Number: 315-30-0

Molecular Formula: C5H4N4O

Purity: Allopurinol 98% purity

About Allopurinol

Allopurinol (CAS 315-30-0) remains the primary xanthine oxidase inhibitor for the management of chronic gout and hyperuricemia, with US-based CDMOs increasingly focusing on high purity fine chemicals to meet the stringent USP and EP monographs required for Pharma/API purity 99% formulations. 1H-Pyrazolo[3,4-d]pyrimidin...

Allopurinol Specifications

CAS Number
315-30-0
Molecular Formula
C5H4N4O
Molecular Weight
136.111
IUPAC Name
6-methyl-2-(4-methylphenyl)sulfonyl-3,7a-dihydro-1H-pyrano[3,4-c]pyrrole / 1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one
Canonical SMILES
C1=NNC2=C1C(=O)NC=N2
InChI Key
RXSUDKHDERGNSY-UHFFFAOYSA-N
InChI
1S/C15H17NO3S/c1-11-3-5-15(6-4-11)20(17,18)16-8-13-7-12(2)19-10-14(13)9-16/h3-7,10,13H,8-9H2,1-2H3
EINECS Number
206-254-8
MDL Number
MFCD00005705
UNSPSC Code
41116107
HSN No
30049099
Molecular Weight
136.111
PSA
74.430
LogP
-0.35380
Physical State
White to Off-White Solid
Density
1.89g/cm3
Boiling Point
290.8ºC at 760 mmHg
Melting Point
350ºC
Flash Point
129.7ºC
Refractive Index
1.816
Water Solubility
0.35 g/L (25 ºC)
Purity
Allopurinol 98% purity
Risk Statements Code
R25;R36/37/38;R43
Safety Statements Code
S24;S26;S36/37/39;S45

Xanthine Oxidase Inhibitor

A potent medication used to reduce the production of uric acid in the body, primarily indicated for the chronic management of gout, the prevention of tumor lysis syndrome during chemotherapy, and the treatment of recurrent calcium oxalate or uric acid kidney stones

Pharmaceutical Active Ingredient

A purine analogue that undergoes hepatic metabolism to its active metabolite, oxypurinol, both of which competitively inhibit the enzyme xanthine oxidase to lower serum and urinary urate concentrations

Antigout Agent

A standard-of-care therapeutic utilized to prevent gouty arthritis and the formation of tophi by maintaining serum uric acid levels below saturation points

Research Tool

A biochemical reagent used in scientific studies to investigate purine catabolism, reactive oxygen species generation, and the role of adenosine signaling in nociceptive pathways.

Stability

Stable in light and air

StorageTemp

15-25°C

Allopurinol FAQs

Minimum Order Quantity

25 kg (evaluation) · 1 MT (commercial)

Lead Time

3 – 5 weeks estimated

Delivery Terms

FOB*

Packaging

20 L pails, 200 L HDPE drums, 1000 L IBC

US Availability

US Facility Inventory

Documentation

US SDS · COA · TDS · Specification sheet

US Regulatory & Quality Information

TSCA status*

US SDS / HazCom*

GHS classification*

ISO 9001:2015 site*

DOT shipping classification*

FDA status*

EPA status*

California Prop 65*

Reliable US supply chain

Regulatory compliance

On-time delivery

Technical expert support

Rounded Top

Explore Pharmaceutical Portfolio

Calcium acetate monohydrate

CAS No : 5743-26-0

Calcium acetate monohydrate

Category : Pharmaceutical Actives & Precursors

Sub-Category : Active Pharmaceutical Ingredients (APIs)

Description : Calcium acetate monohydrate (CAS No: 5743-26-0) occupies a critical position in the global specialit...

View Product
Magnesium Sulphate Monohydrate

CAS No : 14168-73-1

Magnesium Sulphate Monohydrate

Category : Pharmaceutical Actives & Precursors, Inorganic Chemicals

Sub-Category : Active Pharmaceutical Ingredients (APIs), Inorganic Salts

Description : We supply high-efficiency magnesium sulphate monohydrate (CAS No: 14168-73-1) archieved across inter...

View Product
P-Nitrobenzoyl Chloride

CAS No : 122-04-3

P-Nitrobenzoyl Chloride

Category : Pharmaceutical Actives & Precursors

Sub-Category : Intermediates & Precursors

Description : P-Nitrobenzoyl Chloride (CAS 122-04-3) is a critical building block in the API intermediates market,...

View Product
3-(4 Chloro Phenyl) Glutaric Acid

CAS No : 35271-74-0

Category : Pharmaceutical Actives & Precursors

Sub-Category : Active Pharmaceutical Ingredients (APIs)

Description : 3-(4-Chlorophenyl)glutaric acid (CAS 35271-74-0) is a pivotal building block in the API intermediate...

View Product